| Abstrakt: |
A patent application has been submitted for the use of polysaccharide adjuvants in virus vaccines, specifically focusing on their potential to enhance immune responses and improve vaccine efficacy for Beta coronaviruses and influenza viruses. The application discusses the use of a fungal polysaccharide, such as mannan, in combination with alum as an adjuvantation system. It also covers administration methods, potential immune responses, and the reduction of antibody disease enhancement. The patent application describes a method for inducing an immune response against a virus using this adjuvantation system, which includes a fungal polysaccharide and a viral antigen. The method can be used in humans or companion animals, and the adjuvantation system enhances the production of antigen-specific antibodies and promotes an immune response. It also prolongs the protective effect against the viral antigen and reduces the likelihood of antibody disease enhancement. The patent application also describes an adjuvantation system and an immunogenic composition comprising the fungal polysaccharide and viral antigen. [Extracted from the article] |
